Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation

References

• International Diabetes Federation. IDF diabetes atlas – 9th edition; 2019. Available from: https://www.diabetes.org.br/publico/images/Atlas-IDF-2019.pptx.pdf. Accessed March 11, 2021.
   Google Scholar
• Rodríguez-Gutiérrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes. 2016;9(5):504–512. doi:10.1161/CIRCOUTCOMES.116.002901
   Web of Science ®Google Scholar
• Moodahadu LS, Dhall R, Zargar AH, Bangera S, Ramani L, Katipally R. Tight glycemic control and cardiovascular effects in type 2 diabetic patients. Heart Views. 2014;15(4):111–120. doi:10.4103/1995-705X.151084
   Google Scholar
• Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM; American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care. 2003;26(Suppl 1):S106–8.
   Google Scholar
• Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:95–104. doi:10.4137/BMI.S38440
   PubMed Web of Science ®Google Scholar
• Ohde S, Deshpande GA, Yokomichi H, et al. HbA1c monitoring interval in patients on treatment for stable type 2 diabetes. A ten-year retrospective, open cohort study. Diabetes Res Clin Pract. 2018;135:166–171. doi:10.1016/j.diabres.2017.11.013
   Web of Science ®Google Scholar
• World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus abbreviated report of a WHO consultation. Geneva: World Health Organization; 2011.
   Google Scholar
• Sacks DB. Hemoglobin A1c in diabetes: panacea or pointless? Diabetes. 2013;62(1):41–43. doi:10.2337/db12-1485
   Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2019;42(Supplement 1):S1–S2. doi:10.2337/dc19-Sint01
   Web of Science ®Google Scholar
• Weykamp C. HbA1c: a review of analytical and clinical aspects. Ann Lab Med. 2013;33:393–400. doi:10.3343/alm.2013.33.6.393
   PubMed Web of Science ®Google Scholar
• Krhač M, Vučić Lovrenčić M. Update on biomarkers of glycemic control. World J Diabetes. 2019;10(1):1–15. doi:10.4239/wjd.v10.i1.1
   Web of Science ®Google Scholar
• Furusyo N, Hayashi J. Glycated albumin and diabetes mellitus. Biochim Biophys Acta. 2013;1830(12):5509–5514. doi:10.1016/j.bbagen.2013.05.010
   Web of Science ®Google Scholar
• Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J. 2010;57(9):751–762. doi:10.1507/endocrj.K10E-138
   Web of Science ®Google Scholar
• Kosecki SM, Rodgers PT, Adams MB. Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy. Ann Pharmacother. 2005;39(9):1557–1560. doi:10.1345/aph.1G010
   Web of Science ®Google Scholar
• Peacock TP, Shihabi ZK, Bleyer AJ, et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int. 2008;73(9):1062–1068. doi:10.1038/ki.2008.25
   PubMed Web of Science ®Google Scholar
• Inaba M, Okuno S, Kumeda Y, et al.; Osaka CKD Expert Research Group. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol. 2007;18(3):896–903. doi:10.1681/ASN.2006070772
   PubMed Web of Science ®Google Scholar
• Desouza CV, Holcomb R, Rosentock J, et al. Results of a study comparing glycated albumin to other glycemic indices. J Clin Endocrinol Metab. 2020;105(3):677–687. doi:10.1210/clinem/dgz087
   PubMed Web of Science ®Google Scholar
• Araki T, Ishikawa Y, Okazaki H, et al. Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan. J Diabetes Investig. 2012;3(6):492–497. doi:10.1111/j.2040-1124.2012.00224.x
   Web of Science ®Google Scholar
• Hsu P, Ai M, Kanda E, et al. A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan. Atherosclerosis. 2015;242(1):327–333. doi:10.1016/j.atherosclerosis.2015.07.037
   Web of Science ®Google Scholar
• Nakao T, Inaba M, Abe M, et al. Best practice for diabetic patients on hemodialysis 2012. Ther Apher Dial. 2015;19:40–66. doi:10.1111/1744-9987.12299
   Web of Science ®Google Scholar
• MedTech Europe. European IVD Market statistics report; 2019. Available from: https://www.medtecheurope.org/wp-content/uploads/2019/12/2019_MTE_European-IVD-Market-Statistics.pdf. Accessed March 11, 2021.
   Google Scholar
• Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0746-20170505. Accessed October 30, 2020.
   Google Scholar
• EUNetHTA. The HTA core model, version 3.0; January 2016. Available from: http://eunethta.eu/sites/5026.fedimbo.belgium.be/files/HTACoreModel3.0.pdf. Accessed May 13, 2021.
   Google Scholar
• Huang X, Lin J, Demner-Fushman D. Evaluation of PICO as a knowledge representation for clinical questions. AMIA Ann Symp Proc. 2006;359–363.
   PubMedGoogle Scholar
• Schardt C, Adams MB, Owens T, et al. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7:16. doi:10.1186/1472-6947-7-16
   PubMed Web of Science ®Google Scholar
• Critical Appraisal Skills Programme (CASP). Critical Appraisal Skills Programme (CASP); 2015. Available from: https://casp-uk.net/casp-tools-checklists/. Accessed October 30, 2020.
   Google Scholar
• Quinn Patton M. Qualitative research & evaluation methods, third edition. Sage publications; 2002.
   Google Scholar
• Shima K, Komatsu M, Noma Y, Miya K. Glycated albumin (ga) is more advantageous than hemoglobin a1c for evaluating the efficacy of sitagliptin in achieving glycemic control in patients with type 2 diabetes. Intern Med. 2014;53:829–835. doi:10.2169/internalmedicine.53.1364
   Web of Science ®Google Scholar
• Italian Ministry of Health. Outpatients/hospital admission National Reimbursement Tariffs. Available from: https://www.trovanorme.salute.gov.it/norme/renderPdf.spring?seriegu=SG&datagu=28/01/2013&redaz=13A00528&artp=3&art=1&subart=1&subart1=10&vers=1&prog=001. Accessed October 30, 2020.
   Google Scholar
• Istituto Nazionale di Statistica. Il diabete in Italia; 2017. Available from: https://www.istat.it/it/files//2017/07/REPORT_DIABETE.pdf. Accessed October 30, 2020.
   Google Scholar
• Associazione Medici Diabetologi. Le monografie degli Annali AMD. Diabete, Obesità e Malattia Cardiovascolare: lo scenario italiano; 2019. Available from: http://aemmedi.it/wp-content/uploads/2019/01/Annali-AMD-2018-password.pdf. Accessed October 30, 2020.
   Google Scholar
• Mitton C, Dionne F, Damji R, Campbell D, Bryan S. Difficult decisions in times of constraint: criteria based resource allocation in the vancouver coastal health authority. BMC Health Serv Res. 2011;11(1):169. doi:10.1186/1472-6963-11-169
   Web of Science ®Google Scholar
• Berg B. Qualitative Research Methods for the Social Sciences. MA: Pearsons Education Inc.; 2009.
   Google Scholar
• Kitzinger J. Qualitative research. Introducing focus groups. Br Med J. 1995;311(7000):299. doi:10.1136/bmj.311.7000.299
   PubMed Web of Science ®Google Scholar
• Jansen H. The logic of qualitative survey research and its position in the field of social research methods. 2010.
   Google Scholar
• Mullen PD, Reynolds R. The potential of grounded theory for health education research: linking theory and practice. Health Educ Behav. 1978;6(3):280–294.
   Google Scholar
• Spiegelhalter DJ, Myles JP, Abrams KR. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. New York: Wiley N.Y; 2003.
   Google Scholar
• Bernardo JM, Smith AFM. Bayesian Theory. West Sussex, England: John Wiley & Sons Ltd; 1994.
   Google Scholar
• Won HK, Kim KJ, Lee BW, Kang ES, Cha BS, Lee HC. Reduction in glycated albumin can predict change in hba1c: comparison of oral hypoglycaemic agent and insulin treatments. Diabet Med. 2012;29:74–79. doi:10.1111/j.1464-5491.2011.03386.x
   PubMed Web of Science ®Google Scholar
• Koga M, Murai J, Saito H, Kasayama S. Prediction of near-future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes. J Diabetes Investig. 2011;2:304–309. doi:10.1111/j.2040-1124.2011.00107.x
   Web of Science ®Google Scholar
• Lu JM, Ji LN, Li YF, et al. Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: a multicenter, prospective study. J Diabetes Complications. 2016;30:1609–1613. doi:10.1016/j.jdiacomp.2016.07.007
   Web of Science ®Google Scholar
• Li ZL, Liu JC, Liu SB, Li XQ, Yi DH, Zhao MG. Improvement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus. PLoS One. 2012;7(6).
   Web of Science ®Google Scholar
• Murea M, Moran T, Russell GB, et al. Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis. Am J Nephrol. 2012;36(5):488–496. doi:10.1159/000343920
   PubMed Web of Science ®Google Scholar
• Song SO, Kim KJ, Lee BW, Kang ES, Cha BS, Lee HC. Serum glycated albumin predicts the progression of carotid arterial atherosclerosis. Atherosclerosis. 2012;225(2):450–455. doi:10.1016/j.atherosclerosis.2012.09.005
   Web of Science ®Google Scholar
• Xue Y, Sheng Y, Dai H, Cao H, Liu Z, Li Z. Risk of development of acute pancreatitis with pre-existing diabetes: a meta-analysis. Eur J Gastroenterol Hepatol. 2012;24(9):1092–1098. doi:10.1097/MEG.0b013e328355a487
   PubMed Web of Science ®Google Scholar
• Giglio RV, Lo Sasso B, Agnello L, et al. Recent updates and advances in the use of glycated albumin for the diagnosis and monitoring of diabetes and renal, cerebro- and cardio-metabolic diseases. J Clin Med. 2020;9:3634. doi:10.3390/jcm9113634
   Web of Science ®Google Scholar
• Patti AM, Rizvi AA, Giglio RV, Stoian AP, Ligi D, Mannello F. Impact of glucose-lowering medications on cardiovascular and metabolic risk in type 2 diabetes. J Clin Med. 2020;9:912. doi:10.3390/jcm9040912
   Web of Science ®Google Scholar
• Gram-Hansen P, Eriksen J, Mourits-Andersen T, Olesen L. Glycosylated haemoglobin (HbA1c) in iron- and vitamin B12 deficiency. J Intern Med. 1990;227(2):133–136. doi:10.1111/j.1365-2796.1990.tb00131.x
   PubMed Web of Science ®Google Scholar
• Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112(3):126–128. doi:10.1159/000079722
   PubMed Web of Science ®Google Scholar
• Church D, Simmons D. More evidence of the problems of using HbA1c for diagnosing diabetes? The known knowns, the known unknowns and the unknown unknowns. J Intern Med. 2014;276(2):171–173. doi:10.1111/joim.12200
   Web of Science ®Google Scholar
• Danese E, Montagnana M, Nouvenne A, Lippi G. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes. J Diabetes Sci Technol. 2015;9(2):169–176. doi:10.1177/1932296814567227
   PubMedGoogle Scholar